Get started
Author

Chinenye Iwuji

Observed names: C Iwuji, C. Iwuji, Chinenye O O Iwuji, Chinenye OO Iwuji, Chinenye Oluchi Iwuji
Observed institutions: Northwestern University, University of Leicester, Leicester Royal Infirmary, Leicester General Hospital, Southampton General Hospital, University Hospitals of Leicester NHS Trust, Lagos State Health Service Commission, University College London
ORCID: 0000-0001-6927-0816
Observed ORCID: 0000-0001-6927-0816
OpenAlex ID: A5035249153
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
2019 · John N Primrose, Richard P Fox, et al. · The Lancet Oncology · 1,276
PDF
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial
2019 · Lynne M Howells, Chinenye O O Iwuji, et al. · Journal of Nutrition · 246
PDF
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
2015 · Mark I. James, Chinenye Iwuji, et al. · Cancer Letters · 185
PDF
Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
2016 · Vicenç Ruiz de Porras, Sara Bystrup, et al. · Scientific Reports · 138
PDF
A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma
2016 · Julien Edeline, Jean‐Frédéric Blanc, et al. · Liver International · 94
Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial
2015 · Glen RB Irving, Chinenye OO Iwuji, et al. · Trials · 71
PDF
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit
2021 · Alexa Childs, Nekisa Zakeri, et al. · British Journal of Cancer · 42
PDF
Sorafenib for the Treatment of Advanced Hepatocellular Cancer – a UK Audit
2016 · J. King, D.H. Palmer, et al. · Clinical Oncology · 33
Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy
2021 · P.J. Ross, H.S. Wasan, et al. · ESMO Open · 30
PDF
Oncology practice in the COVID-19 pandemic: a report of a Nigerian expert panel discussion (oncology care in Nigeria during the COVID-19 pandemic)
2020 · Adeniyi Adedayo Olabumuyi, Musa Ali-Gombe, et al. · Pan African Medical Journal · 18
Risk of financial catastrophe for breast cancer patients in Nigeria: A retrospective analysis
2024 · Norah N. Zaza, Matt Caputo, et al. · The American Journal of Surgery · 9
Catastrophic health expenditures for colorectal cancer care: A retrospective analysis of the first private comprehensive cancer center in Lagos, Nigeria
2024 · Frankie I. Uwechue, Matt Caputo, et al. · The American Journal of Surgery · 6
Cancer chemoprevention
2014 · Chinenye Iwuji, Lynne Howells, et al. · European Journal of Cancer Prevention · 5
PanCO: An open-label, single-arm pilot study of phosphorus-32 (P-32; Oncosil) microparticles in patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) in combination with FOLFIRINOX or gemcitabine + nab-paclitaxel (GNP) chemotherapies.
2019 · Paul J. Ross, Daniel Croagh, et al. · Journal of Clinical Oncology · 3
Strong tumour cytidine deaminase (CDA) staining predicts for improved survival associated with sequential nab-Paclitaxel (nabP) and gemcitabine (GEM) chemotherapy as first line treatment of patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC)
2017 · P. Corrie, W. Qian, et al. · Annals of Oncology · 3
Evaluating the impact of financial navigation on financial catastrophe and distress for cancer care: a randomized control trial—COST-FIN
2026 · Amir H. Sohail, Oluwasegun Afolaranmi, et al. · Trials · 2
The State of Palliative Care in Nigeria: A Scoping Review
2026 · Colleen E. Witty, Joy Ogunmuyiwa, et al. · Journal of Pain and Symptom Management · 2
PDF
Cancer care financing in Nigeria: A scoping review of the literature
2025 · Sophia Okeke, Oluwasegun Afolaranmi, et al. · Surgical Oncology Insight · 2
PDF
O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy
2020 · P. Ross, A. Hendlisz, et al. · Annals of Oncology · 2
Barriers and facilitators of adoption and implementation of a financial navigation program: cost-fin trial
2026 · Adewale Isaiah Oyewole, Funmilola Olanike Wuraola, et al. · ecancermedicalscience · 1
PDF
Tracking circulating cell free tumour derived DNA in patients with neuroendocrine neoplasms
2021 · Shailesh Gohil, Karen Page, et al. · Endocrine Abstracts · 1
Exploratory Use of Cloud Computing and Social Media for Prostate Cancer Advocacy in Nigeria
2018 · K. Eguzo, A. Jacob, et al. · Journal of Global Oncology · 1
UK audit of sorafenib for advanced hepatocellular cancer
2013 · J. E. King, Parker Johnson, et al. · 1
Financial and structural drivers of cancer care delays in Nigeria: Evidence from the COST-FIN randomized trial
2026 · Nikhil Sriram, Funmilola Olanike Wuraola, et al. · Surgical Oncology Insight
Technological leap or equity trap? Emerging cancer detection technologies and the risk of widening health disparities in Africa
2026 · Kelechi Njoku, Chinenye Iwuji · The Lancet Regional Health - Africa
Works count: 41
Citation count: 2,170
H-index: 10
I10-index: 10
Year
Topic
Type